Phase II study of everolimus and temozolomide as 1-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms (NET G3 and NEC)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt

  • S. Morken
  • Langer, Seppo W.
  • A. Sundlov
  • S. Detlefsen
  • M. Krogh
  • E. Tabaksblat
  • G. O. Hjortland
  • J. B. Svensson
  • J. Assmus
  • A. Couvelard
  • A. Perren
  • H. Sorbye
OriginalsprogEngelsk
TidsskriftJournal of Neuroendocrinology
Vol/bind34
Udgave nummerS1
Sider (fra-til)181-181
Antal sider1
ISSN0953-8194
DOI
StatusUdgivet - 2022
Begivenhed19th Annual ENETS Conference on the Diagnosis and Treatment of Neuroendocrine Tumor Disease - Baltimore, Spanien
Varighed: 10 mar. 2022 → 11 mar. 2022

Konference

Konference19th Annual ENETS Conference on the Diagnosis and Treatment of Neuroendocrine Tumor Disease
LandSpanien
ByBaltimore
Periode10/03/2022 → 11/03/2022

ID: 335686772